Pharming Group N.V. (AMS: PHARM)
Netherlands
· Delayed Price · Currency is EUR 0.682
0.00 (0.00%)
Sep 4, 2024, 5:35 PM CET
Pharming Group Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 30.67 | 31.65 | 29.39 | 31 | 15.59 | 3.83 | Upgrade
|
| Depreciation & Amortization | 18.23 | 18.23 | 18.06 | 15.35 | 16.38 | 19.25 | Upgrade
|
| Other Amortization | 3.79 | 3.79 | 3.27 | 3.11 | 4.44 | 4.36 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 10.43 | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 1.14 | - | Upgrade
|
| Stock-Based Compensation | 0.86 | 1.72 | -0.19 | 2.48 | 0.22 | 0.1 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.37 | 0.37 | 0.01 | 0.9 | 0.95 | 2.1 | Upgrade
|
| Other Operating Activities | 12.24 | 2.83 | 0.11 | 6.36 | 8.52 | -0.13 | Upgrade
|
| Change in Accounts Receivable | -24.37 | -53.85 | -49.82 | -50.13 | 55.09 | -15.19 | Upgrade
|
| Change in Accounts Payable | 2.64 | 7.84 | 11.47 | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | 1.42 | -4.85 | 3.61 | 7.65 | -9.74 | 4.99 | Upgrade
|
| Operating Cash Flow | 45.84 | 7.73 | 26.33 | 16.72 | 92.59 | 19.3 | Upgrade
|
| Operating Cash Flow Growth | 207.16% | -70.63% | 57.53% | -81.95% | 379.72% | - | Upgrade
|
| Capital Expenditures | -3.08 | -3 | -3.09 | -2.22 | -3.64 | -3.7 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.02 | 0.02 | 0.05 | - | 0.02 | 0.51 | Upgrade
|
| Cash Acquisitions | -0.71 | - | -0.73 | -28.63 | - | - | Upgrade
|
| Divestitures | - | - | -9.5 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -7.59 | -8.73 | -8.18 | -4.32 | -3.57 | -2.79 | Upgrade
|
| Other Investing Activities | -0 | -0 | - | - | - | - | Upgrade
|
| Investing Cash Flow | -9.96 | -11.31 | -21.45 | -35.17 | -7.19 | -5.98 | Upgrade
|
| Long-Term Debt Issued | - | 59.97 | 18.63 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -14.01 | -14.73 | -12.67 | -14.9 | -15.19 | Upgrade
|
| Net Debt Issued (Repaid) | 55.79 | 45.96 | 3.9 | -12.67 | -14.9 | -15.19 | Upgrade
|
| Repurchase of Common Stock | - | - | - | -1.98 | - | - | Upgrade
|
| Common Dividends Paid | -27.77 | -27.72 | -22.68 | -15.17 | - | -12.65 | Upgrade
|
| Other Financing Activities | -9.95 | -2.22 | -2.24 | -2.08 | -2.54 | -1.85 | Upgrade
|
| Financing Cash Flow | 18.07 | 16.02 | -21.02 | -31.9 | -17.44 | -29.69 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.3 | -3.08 | 3.24 | 4.21 | -4.95 | 1.56 | Upgrade
|
| Net Cash Flow | 53.66 | 9.36 | -12.9 | -46.14 | 63.01 | -14.8 | Upgrade
|
| Free Cash Flow | 42.76 | 4.74 | 23.25 | 14.5 | 88.95 | 15.61 | Upgrade
|
| Free Cash Flow Growth | 274.28% | -79.63% | 60.31% | -83.70% | 469.98% | - | Upgrade
|
| Free Cash Flow Margin | 3.10% | 0.36% | 1.97% | 1.61% | 9.97% | 1.50% | Upgrade
|
| Free Cash Flow Per Share | 0.85 | 0.09 | 0.46 | 0.29 | 1.76 | 0.31 | Upgrade
|
| Cash Interest Paid | 5.22 | 3.38 | 0.75 | 0.14 | - | - | Upgrade
|
| Cash Income Tax Paid | 8.25 | 19.19 | 23.56 | 10.24 | 4.32 | 12.54 | Upgrade
|
| Levered Free Cash Flow | 32.72 | 7.9 | 8.15 | 10.38 | 84.43 | 11.77 | Upgrade
|
| Unlevered Free Cash Flow | 35.52 | 10.55 | 8.89 | 10.77 | 84.73 | 12.41 | Upgrade
|
| Change in Net Working Capital | 10.78 | 36.6 | 38.84 | 32.82 | -57.45 | 15.69 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.